Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases.
Rev Soc Bras Med Trop
; 46(4): 525-7, 2013.
Article
em En
| MEDLINE
| ID: mdl-23982103
Artemisinin-based combination therapy-resistant malaria is rare in Sub-Saharan Africa. The World Health Organization identifies monitoring and surveillance using day-3 parasitaemia post-treatment as the standard test for identifying suspected artemisinin resistance. We report three cases of early treatment failure due to possible artemisinin-based combination therapy-resistant Plasmodium falciparum malaria. All cases showed adequate clinical and parasitological responses to quinine. This study reveals a need to re-evaluate the quality and efficacy of artemisinin-based combination therapy agents in Nigeria and Sub-Saharan Africa.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Quinina
/
Malária Falciparum
/
Artemisininas
/
Antimaláricos
Tipo de estudo:
Prognostic_studies
Limite:
Adult
/
Female
/
Humans
/
Middle aged
País/Região como assunto:
Africa
Idioma:
En
Revista:
Rev Soc Bras Med Trop
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Nigéria
País de publicação:
Brasil